Fortune 500 Pharmaceutical Company Legacy Real Estate Asset Closure and Divestiture Strategy

Fortune 500 Pharmaceutical Company Legacy Real Estate Asset Closure and Divestiture Strategy (client confidential)


Illustration of an idea and implementation of urban design

Project
Fortune 500 Pharmaceutical Company Legacy Real Estate Asset Closure and Divestiture Strategy (client confidential)

Project Description
Financial restructure and divestiture analysis of a large tract R&D facility

Project Background
Asset and liability assessment, quantification, monetization, and mitigation analysis, including environmental remediation and demolition liability

Business Plan
Market feasibility study, highest and best use analysis and development of a TOD-oriented master plan for mixed use residential, retail, and office use/reuse.

The RESIGHT Solution
Identification and financial analysis of a range of divestiture/reuse options including like-kind sale, “as is, where is” sale, mixed use residential/commercial sale/leaseback and long-term custodial care

Simple Share Buttons